Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
The Inquiry Report
Additional Compensation report
First Interim Report
Second Interim Report
Compensation Framework Study
Evidence
Evidence
Hearings Archive
Compensation
Support
NHS Psychological Support
Confidential Psychological Support
Support Groups
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Contact us
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
A report from the solicitors representing the defendant health authority in the litigation recorded they were "unable" to show that cryoprecipitate and NHS Factor 8 concentrate were not available. Dr Martin "says that he gave no consideration to alternative treatment."
Published on:
30 September, 2024
Dr Winter described how at the around when the Sheffield study took place most clinicians seemed to ignore the issue of NANBH as blood products has brought such miraculous results and so the issues seemed to outweigh the benefits.
Published on:
27 September, 2024
Dr Winter stated that that the Preston paper was a key moment as the general attitude moved from mild to very concerned.
Published on:
27 September, 2024
In oral evidence Dr Mark Winter described how in the 1980s, despite the growing concern of the hepatitis virus, treatment with factor concentrates continued unabated.
Published on:
27 September, 2024
With respect to the growing prevalence of AIDS and the response of UKHCDO, Dr Winter explained how the issue with blood products was that there were constantly new viruses being discovered.
Published on:
27 September, 2024
Dr Winter described how the San Francisco cases in 1982 led to the start of haemophilia doctors understanding they were dealing with a transmissible blood disease.
Published on:
27 September, 2024
Dr Winter described how there are two major problems with concentrate therapy. Firstly, liver disease was much more significant than they thought. Secondly, they required a lot more information to understand what the disease was, how to test for it and how to respond.
Published on:
27 September, 2024
Dr Winter stressed that all haemophilia clinicians were on alert by the end of 1982 on what was occurring regarding the AIDS epidemic.
Published on:
27 September, 2024
Dr Winter explained to the Penrose inquiry that around December 1982, all doctors would have had to interpret the reports from San Francisco that three patients had received blood infected with HIV, and so conclude that HIV was a transmissible disease through blood/blood products.
Published on:
27 September, 2024
Dr Winter held that by 1982, there should have been 'alarm bells' over the potential seriousness of the HIV virus.
Published on:
27 September, 2024
With regards to treatment taking place at Guy's Hospital and Margate, Dr Winter, who worked as one of the senior registrars held that there was never enough NHS commercial concentrate.
Published on:
27 September, 2024
Dr Winter held that due to the shortage taking place at Guy's Hospital and Margate, Tooting Bec hospital had to cover the shortage.
Published on:
27 September, 2024
Dr Winter held that due to the shortage Shortfalls were covered by the use of commercial concentrate, and cryoprecipitate was in limited use only for mild haemophilia or von Willebrand disorder, or occasionally for a child or rarely treated adult.
Published on:
27 September, 2024
With regards to treatment taking place at Guy's Hospital and Margate, Dr Winter held that patients diagnosed with moderate haemophilia may have also received commercial concentrates
Published on:
27 September, 2024
With regards to treatment taking place at Guy's Hospital and Margate, Dr Winter held that patients diagnosed with mild haemophilia may have also received commercial concentrates, in instances where DDAVP was proving ineffective.
Published on:
27 September, 2024
With regards to treatment taking place at Guy's Hospital and Margate, Dr Winter held that while children were prioritised for being treated with NHS products and that prophylactic treatment for children, there was a possibility that children received commercial concentrates too.
Published on:
27 September, 2024
With regards to treatment taking place at Guy's Hospital and Margate, Dr Winter held that with regards to the treatment of children, the general practice was that children were not given concentrate unless they absolutely needed it.
Published on:
27 September, 2024
Dr Winter took the post as director at the Haemophilia Centre in Margate in December 1983.
Published on:
27 September, 2024
Dr Winter held that at the Haemophilia Centre in Margate that around the time of 1983, there was a serious lack of funding.
Published on:
27 September, 2024
Dr Winter explained that no one approached Tooting hospital to help address the issue of cryoprecipitate supplies.
Published on:
27 September, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2340
Page
2341
Page
2342
Page
2343
Current page
2344
Page
2345
Page
2346
Page
2347
Page
2348
…
Next page
Next
Last page
Last